| Spikevax LP.8.1 - | | 70205001 | | Moderna Switzerland GmbH | | Spikevax LP.8.1 | | 06.08.2025 | | | | | 06.08.2025 | | (J07BN01) | | | | WHO-DDD | | 05.08.2030 | | 80000. | | | | 08.08. | | | | | | | | Nein | | | | FI | | PI | | 74.72 | | | | 10% | | 96.45 | | FB | | | | 7680702050010 | | Impfstoffe | | | | |
| | Zusammensetzung | | Suspension: SARS-CoV-2 LP.8.1 mRNA 50 µg pro dosi, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas, cholesterolum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus, trometamolum, trometamoli hydrochloridum, acidum aceticum, natrii acetas trihydricus, saccharum, aqua ad iniectabile, pro dosi, natrium 0.017 mg pro dosi. | | Packungsbestandteile | | | | BAG: Wirkstoffe | Stärke |
|---|
| Sars-Cov-2 lp.8.1 Mrna | 50 mcg |
| | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| 1,2-dimyristoyl-Rac-Glycero-3-Polyethylenglycoli | 2000 | | | 1,2-distearoyl-Sn-Glycero-3-Phosphocholinum | | | | Acidum Aceticum | | | | Aether Methylicus | | | | Cholesterolum | | | | Mrna | 50 µg | | | Natrii Acetas Trihydricus | | | | Natrium | 0.017 mg | | | Saccharumaqua | | | | Sars-Cov-2 lp. | 8.1 | Suspension | | Trometamoli Hydrochloridum | | | | Trometamolum | | |
| |
| | Quelle | | | |
|
|
